Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis
Clinical trial NCT05803135 · UNKNOWN
Trial details
- NCT number
- NCT05803135
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2025-01-30
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.